Diagnostic Imaging Devices - Poland

  • Poland
  • Poland's Diagnostic Imaging Devices market market is forecasted to achieve a revenue of US$0.45bn by 2024.
  • It is estimated that the market will exhibit a Compound Annual Growth Rate (CAGR 2024-2029) of 4.10%, leading to a market volume of US$0.55bn by 2029.
  • In terms of global comparison, the United States is expected to generate the highest revenue, reaching US$11,930.00m in 2024.
  • Poland is experiencing a growing demand for advanced diagnostic imaging devices, driven by the country's increasing healthcare infrastructure and rising focus on early disease detection.

Key regions: Germany, Japan, Netherlands, Spain, United States

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Diagnostic Imaging Devices market in Poland is experiencing steady growth due to increasing customer preferences for advanced medical imaging technologies, favorable market trends, local special circumstances, and underlying macroeconomic factors.

Customer preferences:
In Poland, customers are increasingly preferring diagnostic imaging devices that offer accurate and detailed imaging results. The demand for advanced imaging technologies such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and X-ray systems is on the rise. Customers are also looking for devices that provide faster imaging results, improved image quality, and enhanced patient comfort. Additionally, there is a growing preference for portable and handheld imaging devices that can be used in remote areas or during emergencies.

Trends in the market:
One of the key trends in the Diagnostic Imaging Devices market in Poland is the adoption of digital imaging technologies. Digital imaging systems offer several advantages over traditional film-based systems, including faster image acquisition, easy storage and retrieval of images, and the ability to share images electronically. This trend is driven by the increasing availability of digital imaging devices and the growing use of Picture Archiving and Communication Systems (PACS) in healthcare facilities. Another trend in the market is the integration of artificial intelligence (AI) and machine learning (ML) technologies into diagnostic imaging devices. AI and ML algorithms can analyze medical images and assist healthcare professionals in detecting and diagnosing diseases. This trend is driven by the need for more accurate and efficient diagnosis, as well as the advancements in AI and ML technologies.

Local special circumstances:
Poland has a well-developed healthcare infrastructure, with a growing number of hospitals, clinics, and diagnostic centers. The government has been investing in the modernization of healthcare facilities, including the procurement of advanced diagnostic imaging devices. This has created a favorable market environment for the growth of the Diagnostic Imaging Devices market in Poland.

Underlying macroeconomic factors:
The Diagnostic Imaging Devices market in Poland is also influenced by underlying macroeconomic factors. The country has a stable economy with a growing GDP and a rising disposable income. This has led to an increase in healthcare spending, including investments in medical equipment and technologies. Additionally, Poland has a large aging population, which is driving the demand for diagnostic imaging devices for the diagnosis and monitoring of age-related diseases. In conclusion, the Diagnostic Imaging Devices market in Poland is witnessing growth due to increasing customer preferences for advanced imaging technologies, the adoption of digital imaging systems, the integration of AI and ML technologies, favorable local circumstances, and underlying macroeconomic factors. The market is expected to continue growing as the demand for accurate and efficient diagnostic imaging solutions continues to rise.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)